A detailed history of Amh Equity LTD transactions in Biodesix Inc stock. As of the latest transaction made, Amh Equity LTD holds 696,073 shares of BDSX stock, worth $807,444. This represents 1.71% of its overall portfolio holdings.

Number of Shares
696,073
Previous 696,073 -0.0%
Holding current value
$807,444
Previous $1.06 Million 16.45%
% of portfolio
1.71%
Previous 1.48%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$1.21 - $1.71 $842,248 - $1.19 Million
696,073 New
696,073 $1.06 Million

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $46.4M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Amh Equity LTD Portfolio

Follow Amh Equity LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amh Equity LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amh Equity LTD with notifications on news.